FendX Technologies, a nanotech company developing protective coatings, has entered into a license agreement with McMaster University to commercialize a spray coating that repels and kills pathogens on high-touch surfaces.
Developed by researchers at McMaster, the coating has demonstrated a 99.9% reduction in the transfer of bacterial virus Phi6 and methylene-resistant Staphylococcus aureus (MRSA) when sprayed on plastic gloves.
The license agreement gives FendX exclusive global rights to manufacture, sell, market and distribute products developed from the McMaster technology, with no upfront payment. In turn, the university will receive a 4% royalty on net sales of products that harness the technology as well as more than $280,000 in funding to further develop the technology.
“We are extremely pleased to expand our nanotechnology intellectual property portfolio to include a spray coating formulation through this license agreement with our research partner McMaster,” says Carolyn Myers, president and CEO of FendX. “This is an important addition to our current nanotechnology as a potential spray product could be easier to apply to many surfaces and expand our potential market opportunities beyond industrial and commercial applications.”
Source: Street Insider
